Treating the Cause: Surgical and Conservative Options
At a Glance
The primary goal of treating syringomyelia is to address the underlying cause of the blocked fluid rather than just draining the syrinx. Treatment ranges from careful observation for asymptomatic patients to decompression or untethering surgeries for those with worsening symptoms.
Deciding how to manage syringomyelia is a highly individualized process. Because every patient’s “plumbing” is different, doctors use a decision tree to determine whether a “watch and wait” approach or surgical intervention is the most appropriate path forward.
Conservative Management: “Watch and Wait”
If your syrinx was found “by accident” (incidentally) and you are not experiencing any neurological symptoms, your doctor may recommend conservative management [1][2].
- When it’s appropriate: This approach is common for patients who are asymptomatic, meaning they have no pain, weakness, or sensory loss [1].
- The Surveillance Plan: You will typically undergo regular neurological exams and serial MRI scans (often every 6–12 months initially) to ensure the syrinx is not growing and that no new symptoms are developing [3][2].
- Stability: Many people remain stable for decades under observation without ever needing surgery [2].
The Goal of Surgery: Fixing the “Plumbing”
When surgery is necessary—usually due to worsening symptoms or a rapidly growing syrinx—the standard of care is to treat the underlying cause rather than just “draining” the syrinx itself [4][5].
1. Posterior Fossa Decompression (PFD)
This is the most common surgery for syringomyelia caused by a Chiari I Malformation. The goal is to create more space at the base of the skull so fluid (CSF) can flow freely [4][6].
- Bone-Only Decompression: The surgeon removes a small piece of the skull at the back of the head [7].
- Duraplasty: Often, the surgeon will also open the dura (the tough lining around the brain) and sew in a patch to further expand the space [6][7]. While this carries a slightly higher risk of fluid leaks, it is often more effective at shrinking the syrinx in the long term [6][8].
2. Spinal Cord Untethering
If the syrinx is caused by Tethered Cord Syndrome, the surgeon will perform an untethering procedure [9]. By releasing the “stuck” part of the spinal cord, the mechanical tension is relieved, which often allows the syrinx to stabilize or resolve on its own [5][10].
3. Addressing Scars or Tumors
For post-traumatic or post-infectious cases, the surgeon may perform arachnoidolysis—carefully removing scar tissue to restore fluid flow [11]. If a tumor is the cause, removing the tumor is the primary focus [12].
Why Shunts are a “Backup Plan”
In the past, doctors often placed a shunt (a small tube) directly into the syrinx to drain the fluid into another part of the body, like the abdomen (syringo-peritoneal shunt) or the space around the cord (syringo-subarachnoid shunt) [13][14].
Today, shunts are generally considered a secondary or backup option [15][13]. This is because:
- They don’t fix the cause: A shunt drains the fluid but doesn’t fix the “clogged pipe” that caused the syrinx in the first place [16].
- Complication Risks: Shunts can become blocked, migrate, or cause infections, often requiring multiple “revision” surgeries over a lifetime [15][17].
- Refractory Cases: Shunts are typically reserved for refractory cases—meaning the syrinx didn’t improve after a primary decompression—or for cases where the underlying cause cannot be identified (idiopathic) [13][18].
Measuring Success
The primary goal of surgery is stabilization—stopping the syrinx from getting worse and preventing further nerve damage [19][20]. While many patients experience a reduction in syrinx size and an improvement in symptoms, some neurological damage (like certain types of numbness or muscle wasting) may be permanent even after a “successful” surgery [21][22].
Common questions in this guide
When is 'watch and wait' recommended for syringomyelia?
What is the main goal of syringomyelia surgery?
What is a posterior fossa decompression (PFD)?
Why aren't shunts used as the first treatment for a syrinx?
Will surgery reverse my syringomyelia symptoms?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Am I a candidate for 'watch and wait,' or does the current state of my syrinx suggest surgery is necessary now?
- 2.If we choose surgery, will you be performing a 'bone-only' decompression or a decompression with duraplasty? What are the risks and benefits of each for my specific anatomy?
- 3.If the goal is to 'fix the plumbing,' what is the likelihood that my syrinx will shrink or resolve after the primary cause is addressed?
- 4.What is your experience and success rate with performing posterior fossa decompression or untethering?
- 5.Under what circumstances would you consider a syrinx shunt, and why is that not the first option for me?
- 6.What are the 'red flag' neurological changes that should trigger a transition from conservative management to surgical intervention?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (22)
- 1
Chiari I malformation in children-the natural history.
Chatrath A, Marino A, Taylor D, et al.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2019; (35(10)):1793-1799 doi:10.1007/s00381-019-04310-0.
PMID: 31363830 - 2
Long-term outcomes for children with an incidentally discovered Chiari malformation type 1: what is the clinical significance?
Davidson L, Phan TN, Myseros JS, et al.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2021; (37(4)):1191-1197 doi:10.1007/s00381-020-04980-1.
PMID: 33230572 - 3
A Conservative Approach to Clinical Management of Syringomyelia.
Schindel KM, Bustos S, Villate Prieto S
Cureus 2025; (17(11)):e96661 doi:10.7759/cureus.96661.
PMID: 41393540 - 4
Evaluation and Treatment of Patients with Small Posterior Cranial Fossa and Chiari Malformation, Types 0 and 1.
Bogdanov EI, Heiss JD
Advances and technical standards in neurosurgery 2024; (50()):307-334 doi:10.1007/978-3-031-53578-9_11.
PMID: 38592536 - 5
Optimizing Therapeutic Strategies for Syringomyelia Associated with Tethered Cord Syndrome: A Comprehensive Review.
Mosleh MM, Sohn MJ
Children (Basel, Switzerland) 2024; (11(8)) doi:10.3390/children11080961.
PMID: 39201896 - 6
Posterior Fossa Decompression Versus Syringo-Subarachnoid Shunt for Chiari I-associated Syringomyelia: A Systematic Review.
Alzain A, Halabieh S, Hamoud W, et al.
Cureus 2025; (17(12)):e99276 doi:10.7759/cureus.99276.
PMID: 41541935 - 7
Posterior Fossa Decompression with or Without Duraplasty for Chiari I Malformation.
Yahanda AT, Limbrick DD
Neurosurgery clinics of North America 2023; (34(1)):105-111 doi:10.1016/j.nec.2022.08.008.
PMID: 36424050 - 8
Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium.
Akbari SHA, Yahanda AT, Ackerman LL, et al.
Journal of neurosurgery. Pediatrics 2022; (30(1)):39-51 doi:10.3171/2022.2.PEDS21446.
PMID: 35426814 - 9
Holocord syringomyelia caused by tethered cord syndrome: case report and literature review.
Zheng L, Liao Z, Duan H
BMC neurology 2024; (24(1)):439 doi:10.1186/s12883-024-03951-2.
PMID: 39528987 - 10
Surgical outcomes by sectioning a filum terminale in patients with terminal syringomyelia.
Ishisaka E, Usami K, Ogiwara H
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020; (36(12)):3035-3039 doi:10.1007/s00381-020-04615-5.
PMID: 32318892 - 11
Case of Syringomyelia Associated with Ossified Yellow Ligament and Arachnoid Web.
Bamba Y, Fukunaga T, Umegaki M, et al.
NMC case report journal 2022; (9()):365-369 doi:10.2176/jns-nmc.2022-0143.
PMID: 36447751 - 12
Acquired Chiari I Malformation with Syringomyelia Secondary to Colloid Cyst with Hydrocephalus-Case Report and Review of Literature.
Thotakura AK, Marabathina NR
World neurosurgery 2017; (108()):995.e1-995.e4 doi:10.1016/j.wneu.2017.09.012.
PMID: 28899831 - 13
Treatment of selected syringomyelias with syringo-pleural shunt: the experience with a consecutive 26 cases.
Fan T, Zhao X, Zhao H, et al.
Clinical neurology and neurosurgery 2015; (137()):50-6.
PMID: 26143129 - 14
Syrinx to Subarachnoid Shunting for Syringomyelia.
Davidson KA, Rogers JM, Stoodley MA
World neurosurgery 2018; (110()):e53-e59 doi:10.1016/j.wneu.2017.09.205.
PMID: 29017977 - 15
Case report: CSF hypotension secondary to a free syringo-subarachnoid-peritoneal shunt.
Johnson AR, Rugilo CA, Argañaraz RA
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2024; (40(12)):4365-4368 doi:10.1007/s00381-024-06613-3.
PMID: 39254867 - 16
Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia.
Vaquero J, Zurita M, Rico MA, et al.
Cytotherapy 2018; (20(6)):796-805 doi:10.1016/j.jcyt.2018.04.006.
PMID: 29784434 - 17
Syringo-subarachnoid shunt: how I do it.
Soleman J, Roth J, Constantini S
Acta neurochirurgica 2019; (161(2)):367-370 doi:10.1007/s00701-019-03810-x.
PMID: 30666455 - 18
Treatment of Terminal Syrinx With a Syringo-Subarachnoid Shunt and the Novel Use of a Titanium Knot Fastener: A Case Report.
Furst T, Allegakoen J, Jalal MI, et al.
Cureus 2024; (16(11)):e73440 doi:10.7759/cureus.73440.
PMID: 39664128 - 19
Phenotypes and Prognostic Factors of Syringomyelia in Single-Center Patients With Chiari I Malformation: Moniliform Type as a Special Configuration.
Lu C, Ma L, Yuan C, et al.
Neurospine 2022; (19(3)):816-827 doi:10.14245/ns.2244332.166.
PMID: 36203304 - 20
Single-cell transcriptomics reveals ependymal subtypes related to cytoskeleton dynamics as the core driver of syringomyelia pathological development.
Lu C, Wu X, Wang X, et al.
iScience 2023; (26(6)):106850 doi:10.1016/j.isci.2023.106850.
PMID: 37275526 - 21
Phase-contrast magnetic resonance imaging-based predictive modelling for surgical outcomes in patients with Chiari malformation type 1 with syringomyelia: a machine learning study.
Wang H, Lu L, Fan B, Xiao X
Clinical radiology 2025; (83()):106829 doi:10.1016/j.crad.2025.106829.
PMID: 39986143 - 22
Chiari Type 1 malformation: CSF flow dynamics and morphology in the posterior fossa and craniocervical junction and correlation of these findings with syrinx formation.
Yilmaz TF, Toprak H, Sari L, et al.
Neuro-Chirurgie 2022; (68(6)):595-600 doi:10.1016/j.neuchi.2022.06.001.
PMID: 35752467
This page provides general information about syringomyelia treatment options. Always discuss your specific surgical risks and conservative management plan with your neurologist or neurosurgeon.
Get notified when new evidence is published on Syringomyelia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.